BRCA1 and invasive breast carcinoma: All miRNAs selected for qRT-PCR validation, except miR-1287, were differentially expressed in the same direction in qRT-PCR as in microarray analysis between the invasive breast carcinomas and the asymptomatic normal breast tissues of BRCA1 and BRCA2 germ-line mutation carriers (see Table 6).